Stories for Yanping Liang

VTCRI scientist earns third concurrent grant from the National Cancer Institute to study breast cancer

July 11, 2018

Deb Kelly, an associate professor at the Virginia Tech Carilion Research Institute, was awarded $2.1 million by the National Cancer Institute (NCI) to study the protein that gives rise to ...

Scientists identify new target for developing precision treatment in malignant brain tumors

Jan. 25, 2018

A Virginia Tech Carilion Research Institute team has identified a new therapeutic target to treat glioblastoma, the most devastating and common form of brain cancer.

Scientists decode breast cancer protein

Sept. 14, 2017

Scientists at the Virginia Tech Carilion Research Institute have successfully determined the full architecture of the breast cancer susceptibility protein (BRCA1) for the first time. This three-dimensional information provides a ...

Researchers discover how breast cancer mutation in BRCA1 causes protein to self-destruct

Feb. 28, 2017

Scientists at the Virginia Tech Carilion Research Institute found that breast cancer cells can trigger the self-destruction of the tumor-suppressing BRCA1 proteins. They published their results in Scientific Reports, a ...